Omega eyes ‘significant progress’ as profits jump


Medical testing kit maker Omega Diagnostics today reported a 41 per cent jump in annual profits and said it was poised for “significant progress” this year amid trials of its immune system test for HIV patients.

The Alva-based firm, which specialises in test for allergies, food intolerances and infectious diseases, posted an adjusted pre-tax profit of £1.1 million for the year to 31 March, up from £780,000 a year earlier, on turnover 3 per cent higher at £11.6m.

Chairman David Evans the firm’s outlook was “brightened” by the prospects for its Visitect CD4 test, which is undergoing field trials among HIV patients in Africa and India.

He added: “We will make significant progress this year in terms of gaining market acceptance for CD4 and I believe the prospects for the group remain positive.”




Back to the top of the page




In partnership with

Complete coverage of the festivals. Guides. Reviews. Listings. Offers

Let's Go!

No Thanks